£13m NHS bill for ‘mismanagement’ of menstrual bleeds
A landmark UK study has revealed that acute heavy menstrual bleeding (HMB) is placing a significant hidden burden on the NHS, with around £13 million spent annually on… read more.
A landmark UK study has revealed that acute heavy menstrual bleeding (HMB) is placing a significant hidden burden on the NHS, with around £13 million spent annually on… read more.
Road crossings need to slow down to allow people with mobility issues and older pedestrians enough time to use them, research has indicated. The time interval of crossings in the UK… read more.
In November, The Lancet, one of the world’s most esteemed medical journals, launched a new monthly series of case studies that goes beyond clinical diagnoses to illuminate the social and cultural forces… read more.
A new AI model could help radiologists identify brain abnormalities in MRI scans for all conditions including stroke, multiple sclerosis and brain tumours. The study, led by researchers at King’s… read more.
The UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on… read more.
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 (GLP-1)… read more.
Florida desperately needs more primary care doctors and the University of Central Florida’s College of Medicine, armed with a $2.6 million federal grant, is doing its part to… read more.
Biased or misleading medical advice shared by social media influencers can cause harm and requires coordinated action by governments and platforms to protect the public, argue experts in The… read more.
Fresenius announced the launch of its denosumab biosimilars, Conexxence (denosumab) and Bomyntra (denosumab), in Europe. These biosimilars received approval from the European Commission in July 2025 for all… read more.
A major new study by UCL researchers has revealed the challenges faced by London’s 1.3m night workers, including pay inequality, health problems, transport difficulties, safety concerns and a… read more.
Long-term antidepressant use in Australia has risen steadily over the past decade, with the largest increase seen in young people aged 10-24, where rates have more than doubled…. read more.
A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.